Xbiome

company

About

Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.

  • 51 - 100

Details

Last Funding Type
Funding Round
Industries
Artificial Intelligence,Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
51 - 100
Operating Status
Active

Xbiome is the first AI pharmaceutical company in China that specializes in intestinal micro-ecology. It is based on intestinal micro-ecology and relies on AI technology to accurately and personally manage the gut health of 1.3 billion people. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to more quickly develop effective pharmaceuticals.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
¥100M $110M
Xbiome has raised a total of ¥100M $110M in funding over 2 rounds. Their latest funding was raised on Dec 22, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 22, 2021 Series B $100M 1 Detail
Nov 27, 2020 Funding Round 2 Gaorong Capital Detail
Nov 2, 2019 Series B ¥100M 1 Detail
Jun 24, 2019 Series A $10M 1 Gaorong Capital Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Xbiome is funded by 2 investors. Gaorong Capital and Yimei Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Gaorong Capital Series B
Yimei Capital Funding Round